Biogen have said that their drug, aducanumab, can ‘reduce clinical decline’ of patients in the early stages of Alzheimer’s if it is approved.
As agreement between Vertex and NHS England has been signed which covers all of Vertex’s licensed cystic fibrosis medicines.
For the second time this year Astrazenaca has raised its annual drug sales forcecase due to an increase in sales from new cancer treatments.
A third of sexually active British men say they would consider taking a hormonal form of contraception which is the same percentage of British women who currently use such medication.
The final phase of the NHS’ Electronic Prescription Service (EPS) roll-out is set to go live on November 18, beginning with GP practices using the TPP SystmOne system.